#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Phenylketonuria Haemophilia Renal cell carcinoma Multifocal motor neuropathy Leiomyosarcoma metastatic Metastases to central nervous system Toxic epidermal necrolysis Isodicentric chromosome 15 syndrome Polyneuropathy Scedosporium infection Neuroendocrine tumour of the lung Nephropathy Neuroendocrine tumour Splenic marginal zone lymphoma Medullary thyroid cancer More trials…
Learn about Rare Diseases

Mucopolysaccharidosis III – Diagnostics Hairy cell leukaemia Mantle cell lymphoma stage II – Life with Disease Ewing’s sarcoma metastatic – Treatment Medulloblastoma recurrent – Treatment Angiosarcoma recurrent – Trials in Disease Marfan’s syndrome – Trials in Disease Castleman’s disease – Diagnostics Synovial sarcoma – Basic Information VEXAS syndrome – Life with Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Cloxacillin Caspofungin Candesartan Efpegerglucagon Trehalose Dihydrate (Ph.eur.) Gozetotide Cetrimide Carvedilol Albiglutide Cevostamab Octreotide Hydrochloride Miransertib Lidocaine Hydrochloride Ro7247669 Capivasertib 19Cp02 6QC-ICG SIGVOTATUG VEDOTIN Dexchlorpheniramine Fluasterone More therapies…

Learn about Your Condition

Neoplasm malignant Peptostreptococcus infection Habitual abortion Herpes simplex meningitis Exfoliation glaucoma Autoimmune uveitis Skin cancer Eye inflammation Angina pectoris Immune-mediated myositis Sickle cell anaemia Inclusion body myositis Addison's disease Testicular germ cell cancer Amyotrophic lateral sclerosis More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Hereditary optic atrophy

A study testing lenadogene nolparvovec gene therapy injections into the eye to improve vision in patients with ND4 Leber Hereditary Optic Neuropathy

Recruiting

2 1 1
Study on the Safety and Tolerability of STK-002 for Patients with Autosomal Dominant Optic Atrophy

Recruiting

1 1 1
Investigated Diseases:
- Hereditary optic atrophy
Investigated Drugs:
- 18‐Mer Antisense Oligonucleotide Complementary To Opa1 Pre-Mrna
A study to evaluate the effectiveness of nicotinamide in patients with Leber’s hereditary optic neuropathy who have experienced vision loss within the last 18 months

Not yet recruiting

2 1 1 1
Investigated Diseases:
- Hereditary optic atrophy
Investigated Drugs:
- Nicotinamide

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Hereditary optic atrophy

A study testing lenadogene nolparvovec gene therapy injections into the eye to improve vision in patients with ND4 Leber Hereditary Optic Neuropathy

Study on the Safety and Tolerability of STK-002 for Patients with Autosomal Dominant Optic Atrophy

A study to evaluate the effectiveness of nicotinamide in patients with Leber’s hereditary optic neuropathy who have experienced vision loss within the last 18 months

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies